Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Clinical trial NCT02357420 · COMPLETED

Trial details

NCT number: NCT02357420
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Diabetes Mellitus Complications Gastroparesis

Start date: 2015-01-29
Primary completion: 2016-06-09
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.